AIM

The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis

Hyle, emily, p; Jani, ilesh, v; Lehe, jonathan; Su, amanda, e; Wood, robin; Quevedo, jorge; Losina, elena; Bassett, ingrid, v; Pei, pamela, p; Paltiel, a, david; Resch, stephen; Freedberg, kenneth, a; Peter, trevor; Walensky, rochelle, p.

PloS med; 11 (9), 2014

Background: Point-of-care CD4 tests at HIV diagnosis could improve linkage to care in resource-limited settings. Our objective is to evaluate the clinical and economic impact of point-of-care CD4 tests compared to laboratory-based tests in Mozambique. Methods and findings: We use a validated model of HIV...

CD4 Lymphocyte Count/economics, CD4 Lymphocyte Count/methods, Cost-Benefit Analysis/economics, Cost-Benefit Analysis/methods, HIV Infections/diagnosis, HIV Infections/epidemiology, HIV Infections/economics, Health Care Costs, Health Resources/economics, Mozambique/epidemiology, Point-of-Care Systems/economics

Fulltext

Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania

Objective: To estimate the cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) using sulfadoxine-pyrimethamine (SP). Methods: In two previous IPTi trials in Ifakara (United Republic of Tanzania) and Manhiça (Mozambique), SP was administered three times to infants before 9 m...